Hot in Healthcare 2019 will be taking place on Thursday 19 September. Join us at this Benelux healthcare event in Amsterdam to share knowledge, (re)connect and find out what’s hot in healthcare!
The life sciences and healthcare industry is in flux. With technology and innovation reshaping the boundaries of health and healthcare, how do you remain ahead of the curve? How can you add value and contribute to a healthier system?
The first part of our event, Life Sciences Dealmakers, will be organized in collaboration with Kempen. The morning session will kick off with keynote speaker Rudi Pauwels, and offer the opportunity to schedule 1-on-1s with investors. During workshops with speakers like Edwin Moses, scale-ups, investors, VC firms and industry players (pharma and medtech), the morning will also address the latest topics in today’s and tomorrow’s deal making.
In the second part, Future of Healthcare, key topics include sustainability of healthcare companies, covering circularity, artificial intelligence and regulatory challenges. Lucien Engelen will deliver the keynote speech. In the legacy of last year’s ‘coalition of the doing,’ we look forward to gathering stakeholders from across the spectrum to inspire and find common ground on how to make healthcare future proof.
Follow our LinkedIn page for all updates, program announcements and the reveal of more exciting speakers in the next few weeks.
Secure your spot at Hot in Healthcare 2019 now and pre-register!
* Please note that pre-registration does not guarantee access to the event, as places are limited.
CEO / Fellow
Transform.Health / Center for the Edge Deloitte
We are in the midst of a digital transformation across society that brings opportunities and challenges. What used to work isn’t good enough anymore in a world that is increasingly becoming digital.
Achilles Therapeutics, Evox Therapeutics and Virion Biotherapeutics
Dr. Edwin Moses is a serial entrepreneur in life science companies. As CEO, he built two businesses (Oxford Asymmetry International plc and Ablynx nv), led their successful IPOs on the LSE, EuroNext and NASDAQ and raised over €500M in equity and debt financing.
Jan De Kerpel
Moderator (morning session)
Managing Director, Life Sciences & Healthcare
Jan De Kerpel is a seasoned biotech/healthcare business and finance expert with more than 20 years of combined experience in the fields of drug development, equity and growth financing.
Organized by Baker McKenzie in collaboration with Kempen